Donald Notman Ocular Therapeutix, Inc (OCUL) insider trading activity

OCUL Quotes by TradingView

Donald Notman is Chief Financial Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 195,356 shares of OCUL, which is worth approximately $1.28 Million. The most recent transaction as insider was on Feb 05, 2024, when has been sold 6,212 shares (Common Stock) at a price of $4.86 per share, resulting in proceeds of $30,190. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 195K
0% 3M change
40.15% 12M change
Total Value Held $1.28 Million

Donald Notman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 05 2024
BUY
Open market or private sale
$30,190 $4.86 p/Share
6,212 Added 3.08%
195,356 Common Stock
Feb 03 2024
BUY
Grant, award, or other acquisition
-
61,636 Added 23.42%
201,568 Common Stock
Jan 31 2024
SELL
Open market or private sale
$31,843 $4.95 p/Share
6,433 Reduced 4.4%
139,932 Common Stock
Feb 06 2023
SELL
Open market or private sale
$27,458 $4.24 p/Share
6,476 Reduced 4.44%
139,387 Common Stock
Jan 30 2023
BUY
Grant, award, or other acquisition
-
55,556 Added 27.58%
145,863 Common Stock
Feb 03 2022
BUY
Grant, award, or other acquisition
-
55,556 Added 40.5%
81,632 Common Stock
DN

Donald Notman

Chief Financial Officer
Bedford,, MA

Track Institutional and Insider Activities on OCUL

Follow OCULAR THERAPEUTIX, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

News

Receive news related to OCULAR THERAPEUTIX, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCUL